We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Rws Holdings Plc | LSE:RWS | London | Ordinary Share | GB00BVFCZV34 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-2.20 | -1.22% | 177.60 | 177.40 | 178.00 | 179.40 | 177.40 | 179.00 | 848,768 | 16:35:25 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 718.2M | 47.5M | 0.1288 | 13.77 | 662.95M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/6/2018 10:15 | Thanks, Fizzy. I'll check it out. Have a look at SCPA the other Buffetology stock (like RWS) I mentioned a while back - could be some upside imminent there? Edit - SCPA now up 4.3% at e.o.d., Fizzy! | woodhawk | |
08/6/2018 09:30 | Woody KIE looking cheap after 8% fall with near 7% divi. | fizzypop | |
08/6/2018 07:34 | IC tip normally = kiss of death | toffeeman | |
07/6/2018 18:41 | Also now listed as one of IC's 'tips of the week'. | mfhmfh | |
07/6/2018 18:22 | OK, thanks. | woodhawk | |
07/6/2018 17:55 | says Moravia acquisition has 'profoundly' changed the company. and as has been discussed already today organic growth occurring in all the other parts of the business. Nice long-term one to keep in the ISA IMHO. | mfhmfh | |
07/6/2018 17:34 | In your own words? | woodhawk | |
07/6/2018 17:31 | Can't copy and paste | mfhmfh | |
07/6/2018 17:13 | Could you paraphrase the highlights? | woodhawk | |
07/6/2018 17:05 | Buy rating reiterated in today's IC - very positive article. | mfhmfh | |
07/6/2018 17:05 | Buy rating reiterated in today's IC - very positive article. | mfhmfh | |
07/6/2018 15:47 | Does that make any sense at all? | woodhawk | |
07/6/2018 15:37 | - Numis today upgrades its investment rating on RWS Holdings PLC [LON:RWS] to buy (from add) and cut its price target to 450p (from 490p). | broadwood | |
07/6/2018 14:30 | Timing is everything!!! (or nothing!) Just in profit having bought at 3.96 in April before the further drop. | toffeeman | |
07/6/2018 14:22 | Back on the UP escalator for the foreseeable. | broadwood | |
07/6/2018 13:32 | Indeed, concerns over Moravia, new business and exchange rates all evaporated now. Great buying opportunity sub 400p. Well done to those who bought at the lows. Numis upgraded RWS to 'Buy' from 'Add' today. | woodhawk | |
07/6/2018 13:23 | There was concern before today's RNS re: sales at Moravia which was the company's biggest acquisition. This from today: 'accelerating revenue performance at Moravia over the last two months...' All IMHO. GLA. | mfhmfh | |
07/6/2018 11:51 | I think RWS ought to revert to the long term trend line at circa 550p. Currency headwinds have abated and should improve further and all business elements are now on the up, as you say, mfhmfh. BTW - take a look at SCPA (another Buffetology fund core holding, like RWS) which looks similarly beaten down for no good reason. | woodhawk | |
07/6/2018 11:44 | momentum building in all parts of the company... | mfhmfh | |
07/6/2018 11:29 | Would expect this to gain traction over the next few sessions. 450 next week looks well achievable | mad foetus | |
07/6/2018 10:06 | Upgraded by Numis to 'buy' with 450p price target. | robinnicolson | |
07/6/2018 08:20 | Yes, great results. Took some early profit on the spike at 404p. | woodhawk | |
07/6/2018 08:12 | excellent RNS today. US interest rates predicted to be raised at least twice more this year so should improve exchange rate even more. All IMHO. GLA. | mfhmfh | |
07/6/2018 07:42 | RWS said sales increased 82% to £139.6m from £76.6m, including a £52.1m five-month contribution from Moraviain in the six months to 31 March 2018. HIGHLIGHTS: - 5% underlying growth on a constant currency basis - Adjusted operating profit up by 61% to £30.5m (H1 2017: £19m) - Adjusted profit before tax up by 47% to £28.6m (H1 2017: £19.4m) including a £4.7m five-month contribution from Moravia - Underlying growth of 12% on a constant currency basis - £1.8m impact from adverse exchange rate movements - Adjusted earnings per share was up by 19% to 8.2p (H1 2017: 6.9p) Interim dividend increased by 15% to 1.5p (H1 2017: 1.3p) - Net debt at period end of £82.8m (H1 2017: £31.8m), after £242.3m net cash outflow for the acquisition of Moravia and £46.2m outflow for repayment of borrowings, reflecting continued strong underlying cash generation - Acquisition of Moravia funded by a £182m share placing and a $160m refinanced loan facility RWS chairman Andrew Brode said: "RWS has delivered a solid performance over the first half, despite the challenges presented by currency headwinds and we are pleased with the progress we are making with managing the assimilation of Moravia. "The group's trading performance since the period end has been in line with our expectations, and we are pleased to see currency headwinds abating. "Moravia, in particular, has enjoyed an excellent start to the second half with new client wins since its acquisition, and we are encouraged by good momentum across the group. "As the premier global supplier of intellectual property support services, a major force in life sciences and a global player in localisation, we are exceptionally well positioned to drive further international expansion. "The Board is, therefore, confident of further progress in the second half and beyond." | broadwood | |
07/6/2018 07:17 | Mad - all you need to consider is that Brode owns over 30% of the company :) | jimbowen30 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions